Publications

Free To Choose Medicine in Japan: A Model for America

An early version of FTCM was distributed in a Japanese booklet and played a role in Japan’s passage of legislation in 2013 that implemented FTCM principles for regenerative medicine drugs. A Forbes op-ed (December 1, 2015) with the economist Vernon Smith, “Give the FDA Some Competition with Free To Choose Medicine,” click here, highlights the benefits from FTCM and the importance of Japan’s market-based approach. For more information on this topic, click here.